Efficacy and Safety of Tildrakizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis of the Scalp: Week 52 Results From a Phase 3b, Randomized, Double-Blind, Placebo-Controlled Trial

By sjmartinez • December 26, 2024

Sofen HL, Gebauer K, Spelman L, Yamauchi PS, Yao SL, Nishandar T, Kopeloff I, Crane M, Gogineni R, Kothekar M, Bagel J. Efficacy and Safety of Tildrakizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis of the Scalp: Week 52 Results From a Phase 3b, Randomized, Double-Blind, Placebo-Controlled Trial. J Am Acad Dermatol. 2024 Dec 23:S0190-9622(24)03393-0. doi: 10.1016/j.jaad.2024.12.018. Epub ahead of print. PMID: 39722400.

Tags: Dermatology, efficacy, itch, Olive View DoM, psoriasis, Publications, safety, scalp, tildrakizumab

Neutrophil Transcriptomic Changes in Severe Sterile Vasoplegic Syndrome Resemble a Distinct Molecular Subtype of Septic Shock

Siletz AE, Kelly-Scumpia KM, Scumpia PO, Street K, Ragkousis V, Shirazi R, Sanaiha Y, Do TH, Shemin R, Kwon M, Crager S, Benharash P, Cryer[...]

Systemic Pharmacological Treatments for Chronic Plaque Psoriasis

Armstrong AW, Nong Y, Merola JF. Systemic Pharmacological Treatments for Chronic Plaque Psoriasis. JAMA Dermatol. 2026 Mar 25. doi: 10.1001/jamadermatol.2026.0200. Epub ahead of print. PMID:[...]

Ethical Considerations of Excusing Students With Alopecia Areata From Physical Education Activities

Taghizadeh CS, Goh C, Lipner SR. Ethical Considerations of Excusing Students With Alopecia Areata From Physical Education Activities. J Am Acad Dermatol. 2026 Mar 20:S0190-9622(26)00455-X.[...]